Cartalax Research Compound (LAX)

"Premium grade Cartalax validation."

Cartalax is a short peptide with the sequence Ala-Glu-Asp (AED), from the family of short regulatory peptides characterized in the Russian peptide research program for their reported effects on gene expression via nuclear and histone interactions. It is studied in cartilage and extracellular matrix research (Khavinson et al., Molecules 2021, PMID 34834147). Cartalax research peptide is supplied lyophilized at ≥99% purity verified by HPLC, with identity confirmed by mass spectrometry and a batch-specific Certificate of Analysis (COA) included. Store lyophilized powder at −20 °C, protected from light and moisture. For laboratory research use only — not for human or animal consumption.